Thank you for downloading and welcome to Take Orally, the emergency medicine podcast recorded at Dream Queen's Medical Centre at Nottingham. In this episode, we'll be discussing the new NICE sepsis guidelines. As ever, all information is correct at the time of recording. Any guidelines mentioned are correct from Nottingham University Hospital's NHS Trust. Other trust guidelines may vary. All views and opinions are the speaker's own.
Hello, my name's Jamie. I'm one of the teaching fellows in emergency medicine. My name's Chris Goff. I'm one of the consultants in emergency medicine. So welcome back to Take Aurelie, Chris. A few months ago, Chris was with us to talk about sepsis in general. But we thought because of our trust here adopting the new NICE sepsis guidelines, I thought it was a good time to get Chris back in to go through the NICE guidelines with you. So thank you very much for coming back, Chris. Thanks for having me back, Jamie. So yeah, the new NICE guidelines are out and they've been out for about six months now. And so we got to the point where they're becoming the standard of care here at Nottingham University Hospitals. So we thought we'd go through them with some of the new terminology and just kind of how to use them.
So the guidelines in question that we're talking about are NICE guideline NG51, Sepsis, Recognition, Diagnosis and Early Management, published in July last year. We will put a link up to this on both our Twitter and Facebook pages. And the guidelines really cover how we identify and assess people with suspected sepsis, how we stratify them, and then how we manage that suspected sepsis. Yeah, that's perfect. What's really good, and it's probably worth, if you haven't got them out in front of you yet, is pausing the podcast to go get them, are the flowcharts. And there are flowcharts for the under-5s, the 5-12s, and the over-12s in adults. They refer to both primary care and in-hospital. So we're going to use the over-12 in-hospital one. So as I say, we'd probably like people to stop you listening to us. Pause it sec. Go get it in front of you. It's easier to follow through. Okay. So welcome back. I hope you have paused us. So we're now going to start going through the flowcharts now to identify our patient with sepsis. And the first box at the top of the flowchart, Chris, here, says, person with possible infection, and puts even in brackets, you know, think, could this be sepsis?
Yeah, and you've got to be aware that everybody thinks that sexy people have big temperatures and have got really classic symptoms of an infection. It's very obvious, and we know that whilst that's true for a number of people, it's not true for everybody. And as it says in that top box, look at people who've got reasons why you're going to struggle to identify those classic factors. They could be children, especially pre-verbal children, or children who are young and have different physiological parameters to be used to. It can be elderly people who have a habit of disguising things very well. It could be people who don't have English as a first language, and understanding what their complaints are is difficult.
and find people who've got some cognitive impairment who can't tell you what's going on. So if you've got one of those patients, just broaden out your horizon. But if you think someone's got a potential infection, then you need to re-stressify them for sepsis. And it's also mentioned, as well as those patients you spoke about, people who are more vulnerable to sepsis, Chris. So yeah, that's looking at people who might have a reason why their ability to...
tolerance infection is impaired. So very young and very old, very frail. People who've had recent trauma, surgery or invasive procedure, whose body's already had an insult in effect. People have impaired immunity, so that can be either due to an illness or due to the medications we give them. And then anybody who has got an indwelling device, be that a line, a catheter, an implant, or someone like an intravenous drug user who's reaching their skin barrier in less than septic conditions. And then finally, the other thing to think about are the pregnant or recently pregnant patients who also have a high risk for contracting sepsis.
And also then, we'll talk a bit more about source control later on. There's also this early idea here in the assessment box saying, you know, a likely source of infection, so that's in your history taking and in your examination, isn't it? Yeah, and so when you're thinking about a light source infection, you're looking for the symptoms that people give you to give you a guide to where you think this infection might be. So that can be as simple as, I've got a cough with green sputum. I think we'll all agree that's probably going to be a chest infection. I've got pain when I pass water and I pass urine 20 times a day that hurts in the right side of my back. I think we'll all agree that sounds like a UTI in part of nephritis. So things like that, if you've got symptoms that guide you to where it is, brilliant. And so then we're really into risk stratifying our patients. Yeah, so we're on to Zephark flowchart. So this is where the technology is going to change a little bit. So we're talking about high-risk red flag sepsis.
So the way to go through this is just kind of go through the high-risk side, see if people are high-risk or not, and if they're not, you can move down the risk categories. And if they're in the high-risk group, you then work through that bit. So we're going to start on the high-risk side. There's a list of criteria that make people a high-risk red flag substance patient, and you only need one of them to be a high-risk red flag, and these aren't people who need to be sorted out now. These aren't people you're going to say, I'll catch up with them in an hour or so. So the guideline advisor is a senior clinical decision-maker, and in fact, what they really mean is anybody who can prescribe antibiotics, because this is what these patients need. So you're going to do your blood tests. It's going to be looking at signs of inflammatory markers and organ dysfunction, but importantly, the blood cultures are there.
And it's worth remembering that ideally two sets from two sites before antibiotics if you can, but don't delay antibiotics if you can't, and three sites for endocarditis. So having got your blood tests and your blood cultures, the next thing to do is give intravenous antibiotics. The guideline is quite sensible. It doesn't tell you which one to give. And that's because everywhere is a bit different. So if you've got a source...
If you haven't, your trust will have a guideline for sepsis of unknown sorts, and that will cover your local flora, resistance patterns, and what drugs you have available in your pharmacy. And that will be given without delay, and as it says, within one hour of identification of high-risk criteria. And that's important, because that's not one hour of prescription, that's one hour of the patient triggering this red flag sepsis. So that's very, I mean, so here in our emergency department, we have our initial assessment unit where patients first received and brought by an ambulance if they've not already been brought through to recess. That's the opportunity then for the clinician there to identify these red flags early to save time, to save lives. Yeah, and the evidence is out there that for sepsis shock, certainly, it was created around 7% mortality increase for every hour of antibiotics to delay, and that's a very sizable risk. So having given your antibiotics, you'll have your blood tests, or hopefully blood gas back, so on the blood test it says.
to do is a blood gas and a venous blood gas is absolutely fine to get a glucose and a lactate measurement so do that from one of your cannulas and you'll get a lactate and then the lactate will help guide you or the blood pressure will guide you on the need for fluids and generally we tend to be fluid liberal and the one exception here where we might not be so liberal is people who've got a normal lactate and a normal blood pressure so you might just assess their volume status first and feel if they need it but generally we're going to give these people a fluid bolus described here as 500 mils of crystalloid ideally over less than 15 minutes to see how they respond in terms of lactate and physiology. There's no mention of temperature in any of these red flag features and that's a bit of a paradigm shift I think for me and for my students as well. Yeah, and there's always been this idea that some people think that the higher your temperature, the more unwell you are, but there's actually no evidence at all to suggest that. And you see people who've just got viral illnesses who, they don't need antibiotics, they've got viral illness, and they're eye-goring, their temperature's 392, just doesn't mean they're more unwell than someone who's back to remit with a temperature of 376. So the temperature itself isn't necessarily the bill of an end-all and can be affected by recent use of antipyretics as well, which disguises the temperature as a means less septic. And also, this is very, I mean...
And for those who, as maybe Julius had mentioned, discussed with consultants who mentioned you want a senior ST3 or above to really see the patient if possible. But then there's also this mention, if your lactate is above 4 and they're hypertensive to get an early referral into critical care as well. Yeah, so people who've got lactate greater than 4 are low blood pressure. These are the septic shock patients, and these are patients who are highly likely to need invasive lines and blood pressure support. And they may also go on to do things like invasive ventilation or minimal support or things like that, and they're going to need a higher level of care. So you need to be discussing with the critical care team early so you can deliver those interventions early and improve outcomes.
So those are our red flag patients, our high-risk category patients. So moving down, there's the moderate to high-risk criteria, the amber group, if you will. Yeah, that's perfect. We talk about amber or yellow risk or moderate to high-risk criteria. And so, again, a list of generally easy numbers to remember, a couple of subjective things, but most of these things are objective. It's the reason why you think these patients might be a moderate risk, and it's moderate to high-risk or poor outcome from services. So if they have two of these criteria, or their blood pressure is a bit low, but not low enough to trigger as red.
They need some blood tests doing. And these blood tests are looking for if signs of inflammatory markers and things like that. But importantly, what they're looking for is the blood cultures. They need to be done again. See what the lactate's doing. So if the lactate's high, so over two. All they're using these to come back is they've got AKI. These are actually patients who are at high risk of poor outcomes. These then move across into the treatment arm of red flag sepsis. And then you'll have a group of people who have a lactate rate less than two and no AKI. Or you'll have a group of people who only have one moderate high risk criteria. And then you get them seen within a few hours, within three hours of consideration of antibiotics.
or manage an offensive condition if things are those things a little bit less pace if you're happy that they're they're not as unwell but don't forget people's usually don't turn around very quickly so if you send that UNA off and it's going to be back in 60 minutes you need to be making sure you keep an eye on that and that's a quote you know the figure here of within three hours of consideration antibiotics fits in very well with our four hour target down here in A&E you know that they should be getting antibiotics within A&E yeah generally if people need antibiotics for their sepsis then it's got to be given in A&E really there's no excuse for them for not being given I think Some people may worry about the fact that if you've only got one blood-to-high-risk criteria, you get a review within an hour and then think about doing blood tests. So what we do in our department is that if you come in with just one high-risk criteria and you're getting your blood done on arrival, like any other patient would do, to minimise delay in care further down the downstream and reduce delay to antibiotics. And then moving down from our Amber and Yellow group, we've got the Green group, low-risk criteria now.
Yeah, and those are patients who are effectively screened out as being low-risk or anything, so just get a clinical assessment. I know you can be ambulatory patients, you don't have to necessarily line in all your bloods, you don't have to take them to recess or anything like that. And that's you going, I think they've got an infection, they may have some specific effects there, infection, because you can feel degenerating well when you have an infection, but actually they're not triggering anything that says they're going to have a poor outcome. So we've got time to actually clinically assess them, maybe the most appropriate care, while they're going in heavy with early antibiotics and fluids. So, yeah, it's normal behaviour, no high-risk or moderate-to-high-risk criteria in there. So, like you said, they could feel grotty, but there's no sign of organ dysfunction, there's no sign of organ perfusion. And that's what it's all about. So, sepsis is this idea of an atypical or dysregulated response to an infection, and it's a systemic thing, and actually the hallmark is you get organ dysfunction and hyperperfusion, and that's what we're trying to correct, as well as treat the infection. So if you have no evidence of ending up with dysfunction or no evidence of hyperfusion, then you're not septic. So that's why that's there.
And as I said, we talked earlier a bit about matching with the high-risk patients. Still not getting away from the sepsis 6. It's still cornerstone, isn't it? Yeah, and the sepsis 6 covers the basics to give you an option to look after your patients as well. And I always remember it's three things in and three things out. So the three things that you want out of your patient are blood cultures. I'll say it again, because it's something that we know that we're poor at doing, especially in the more unwell patients when things are rushed. So two good, clean sets of cultures. We want urine output monitoring out of your patients to see how well their kidneys are working and also a state of fluid balance status. And you want that lactate out of your patient.
I think what's important, we think about doing one lactate when somebody gets here, but actually making sure you do repeat lactates. Either they're improving, or if a patient gets more unwell, you recheck that lactate to see how you're doing and whether they're actually getting more well in front of you and actually their lactate's going up and their risk is changing. So those are the three things out, and the three things in are fairly simple. It's give them oxygen, give them antibiotics, and give them fluids. And again, it just makes me a little bit...
as a highlight for people following our guidelines with us. It also mentions the AKI NICE guidelines, which are CG169, which people can look at there. I think the AKI is a major source of complication for patients with synopsis and cannot be underestimated and must always be checked into it. Yeah, indeed. And it's one of the things that makes you a high-risk patient. Your kidneys are one of the most sensitive organs to perfusion and also kind of fairly precious. So it's good to make sure they are well looked after. So, again, look at those. And the AKI guideline will have the definition of AKI in there for you to look up at your leisure.
I was told by a doctor at medical school that some organs like the liver are very forgiving, but the kidneys will take you down with them if they don't like things. They just start acting up very early on. Okay, so that's our guidelines. We've re-stratified our patients, and we've talked a bit about the management of the patient as well. So you talked a bit about source control for our patients as well? So, yeah. So, I mean, when you look at the most common sources of infection, the easiest data to have for this is the PROMIS trial from a couple of years ago, looking at UK data. So the majority of people in the PROMIS trial were severe septic shock. About a third of patients had the lungs as their signs of infection. The next two sources were blood and urinary tract.
Fairly easy things. They're going to get antibiotics and organs forward. But actually, there will be times when people have got either a prosthesis that's infected or have got an indwelling linus and have got a foreign body or they've got a collection. And actually, giving them antibiotics is great, but what you really need to do is get the source of that infection out. And so it's having that broad-minded approach. And remembering silly things that count as foreign bodies or indwelling things. So the UTI, the guy who's got a long-term catheter, swap the catheter. Because that catheter's probably where the bugs are coming from. If people have got a cannula in that looks red, it's great you can give antibiotics on it, but you probably want to take it out and put a new one in.
and things like that. The one thing to be careful for are things like Hickman lines. It depends why they're in. And so our trust policy varies by the indications. So our TPN servers are very precious about their Hickman lines. I don't like us pulling them out of source control in the middle of the night. So if they've got something like a tunnelled line, it's worth speaking to the team who are responsible for it, just seeing how precious it is. But otherwise, yeah, anything that's in there you think that shouldn't be there is not normal. And always a collection of us, get it out. And that promise trial that you spoke about, that's the protocolised management and sepsis trial, isn't it? It was a study of...
56 NHS hospitals in England. Yeah, it was one of a trio of studies that were designed to work together. So the promise was the UK one, there was process in the USA and there was a rise in mostly Australia, New Zealand, but also Finland, Hong Kong and Ireland. And it all looked like the protocolised management of sepsis, the old early goal-directed therapy, based on the Marion Rivers paper from the early 2000s, and component that to standard care. And it found that basically our usual care was caught up and no longer is sepsis, somebody who sits in the corner of the infection, and usual care was as good as early goal-directed therapy. And the cornerstones of usual care were...
giving rats ass giving early antibiotics and giving fluids so if you can get all that done you start people from a good place And then finally, Chris, there's just one last cohort of patients we do need to talk about, and those are patients who are at risk of getting neutropenic sepsis. So yeah, neutropenic sepsis is a small subgroup of our sepsis patients. The best way to think about it is anybody who's on anti-cancer treatment is what the NICE guideline would say. And you don't wait for somebody's blood count to come back and tell you if they're neutropenic or not. If you're on anti-cancer treatment and you think they're septic, then you're going to treat them with neutropenic sepsis. The treatment's fairly similar. The NICE guideline just is a bit specific about the antibiotics you give. So generally, everybody should have tazazin as the recommended first-line antimicrobial.
for the utropinic sepsis, but you check your local trust guidelines and policies because you may have a second or third antibody to give with the tazacin. They'll certainly have a what to do with their pen allergic guideline. The other thing to think about in patients who are on antichrist treatment is a lot of these patients may well have total access in, like we mentioned before. You may well go to that for taking their bloods and giving all their therapy, which is fine. They may have poor peripheral veins, but do make sure you get a peripheral set of blood cultures to just see what comes up in those bloods. Because if it's only the line that's growing positive and the peripheral ones are not, it might mean that it's the line that's infected and has big implications for the management of that patient.
And involving the oncology team as well? Yeah, and involving the oncology team early on as well for the interlocal patient is undoubtedly a good idea. What I find is good is a lot of patients I've seen who are on anti-cancer treatment, some of you have presented with me as themselves without, are given an awful lot of information. Many of you are told to monitor their temperatures at home every day, any sign of a pyrexia to present to hospital, there's a risk of getting me as themselves, so that is useful. Yeah, that's brilliant for them, so they self-monitor and they're normally quite switched on, so if they come in to you saying, I'm worried about this, it's well worth listening. A lot of that also is you'll find a lot of patients will go directly to their cancer centre, so as part of that, self-monitoring, they'll be in contact with the oncology nurses.
And so depending on how your site's set up and where the oncology service is, they may well go directly there. So you might not see many of these patients, but you may see them if they're out of area. So just because you're on oncology treatment doesn't mean you can't go on holiday. Or because they've been on well in a public place and someone's called an ambulance that comes to your ED. So bear in mind. Thank you very much for coming, Chris. Not a problem. That was the Take Orally New Nisepsis Guidelines podcast. You can find us on Facebook and Twitter, where we'll put up links to the guidelines mentioned. And you can contact us to suggest topics you'd like to see covered in future episodes. For more information on education and research opportunities within emergency medicine, acute medicine and major trauma, you can find NUH Dream on both Facebook and Twitter.